Commercial Litigation and Arbitration

October 4, 2009

From Novartis Vaccines and Diagnostics, Inc. v. Bayer Healthcare LLC, 2009 U.S. Dist. LEXIS 89117 (E.D. Tex. Sept. 28, 2009): That access to some sources of proof presents a lesser inconvenience now than it might have absent recent developments does not render this factor superfluous." [Volkswagen of America, Inc., 545 F.3d 304, 3 ...
From Novartis Vaccines and Diagnostics, Inc. v. Bayer Healthcare LLC, 2009 U.S. Dist. LEXIS 89117 (E.D. Tex. Sept. 28, 2009): That access to some sources of proof presents a lesser inconvenience now than it might have absent recent developments does…

Recent Articles

Archives